Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection

Clinical and Experimental Immunology

Volumn 111, Issue 2, 1998, Pages 269-277

  Kallinowski, B ^a   Haseroth, K ^a   Marinos, G ^b   Hanck, C ^a   Stremmel, W ^a   Theilmann, L ^a   Singer, M V ^a   Rossol, S ^a,c  

^a Department of Gastroenterology ^*  (Germany)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Chronic hepatitis C; TNF receptors; Tumour necrosis factor alpha

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; RECOMBINANT ALPHA2B INTERFERON; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ADULT; AGED; ANTIGENS, CD; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031887203     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00469.x     Document Type: Article

References (38)

1. Alter HJ, Margolis HS, Krawczynski K et al. The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992; 327:1899-905.
2. Gonzalez-Peralta RP, Davis GL, Lau JY. Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection. J Hepatol 1994; 21:255-9.
3. Lau JY, Davis GL, Kniffen J et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341:1501-4.
4. + T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 1993; 178:17-25.
5. + T lymphocyte epilopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatol 1995; 21:632-8.
6. Vilcek J, Lee TH. Tumour necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 1991; 266:7313-20.
7. Tracey KJ, Vlassara H, Cerami A. Cachectin/tumour necrosis factor. Lancet 1989; i:1122-6.
8. Bird GL, Sheron N, Goka AK, Alexander GJM, Williams R. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990; 112:917-20.
9. Sheron N, Lau JYN, Daniels H et al. Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection. J Hepatol 1991; 12:241-5.
10. Daniels HM, Meager A, Eddleston ALWF, Alexander GJM, Williams R. Spontaneous production of tumour necrosis factor α and interleukin-1β during interferon-α treatment of chronic HBV infection. Lancet 1990; 335:875-7.
11. Smith CA, Davis T, Anderson D et al. A receptor for tumour necrosis factor defines an unusual family of cellular and viral proteins. Science 1990; 248:1019-23.
12. Loetscher H, Pan Y-CE, Lahm H-W et al. Molecular cloning and expression of the human 55 kd tumour necrosis factor receptor. Cell 1990; 61:351-9.
13. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992; 13:151-3.
14. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumour necrosis factor by its soluble receptors. J Exp Med 1992; 175:323-9.
15. Aderka D, Engelmann H, Shemer Avni Y et al. Variation in serum levels of the soluble TNF receptors among healthy individuals. Lymphokine Cytokine Res 1992; 11:157-9.
16. Porteu F, Nathan C. Shedding of tumour necrosis factor receptors by activated human neutrophils. J Exp Med 1990; 172:599-607.
17. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SW. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc Natl Acad Sci USA 1992; 89:7845-9.
18. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatol 1994; 19:1513-20.
19. Kallinowski B, Müller HM, Solbach C, Goeser T, Kabelitz D, Theilmann L. Hepatitis C virus RNA in different blood lymphocyte subsets. Europ J Gastroenterol 1994; 6:249-53.
20. Rossol S, Voth R, Brunner S et al. Corynebacterium parvum (Propionibacterium acnes): an inducer of tumor necrosis factor-alpha in human peripheral blood mononuclear cells and monocytes in vitro. Eur J Immunol 1990; 20:1761-5.
21. Voth R, Rossol S, Klein K et al. Differential gene expression of IFN-alpha and tumor necrosis factor-alpha in peripheral blood mononuclear cells from patients with AIDS related complex and AIDS. J Immunol 1990; 144:970-5.
22. Marinos G, Naoumov NV, Rossol S et al. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterol 1995; 108:1453-63.
23. Böyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 1968; 21 (Suppl. 97):77-89.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium Thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-63.
25. Ehlers S, Mielke ME, Blankenstein T, Hahn H. Kinetic analysis of cytokine gene expression in the livers of naive and immune mice infected with Listeria monocytogenes. The immediate early phase in innate resistance and acquired immunity. J Immunol 1992; 149:3016-22.
26. Hussain MJ, Mustafa A, Gallati H, Mowat AP, Mieli Vergani G, Vergani D. Cellular expression of tumour necrosis factor-α and interferon-γ in the liver biopsies of children with chronic liver disease. J Hepatol 1994; 21:816-21.
27. Cordell JL, Falini B, Erber WN et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32:219-28.
28. Tiegs G, Wolter M, Wendel A. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 1989; 38:627-31.
29. Nagakawa J, Hishinuma I, Hirota K et al. Interleukin-1 alpha enhances hepatotoxicity of tumor necrosis factor-alpha in galactosamine-sensitized mice. Immunopharmacol Immunotoxicol 1991; 13:485-98.
30. Tilg H, Wilmer A, Vogel W et al. Serum levels of cytokines in chronic liver diseases. Gastroenterol 1992; 103:264-74.
31. Larrea E, Garcia N, Qian C, Civeira MP, Prieto J. Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatol 1995; 23:210-7.
32. Tilg H, Vogel W, Dinarello CA. Interferon-alpha induces circulating tumor necrosis factor receptor p55 in humans. Blood 1995; 85:433-5.
33. Diez-Ruiz A, Tilz GP, Gutierrez-Gea F et al. Neopterin and soluble tumor necrosis factor receptor type I in alcoholic cirrhosis. Hepatol 1995; 21:976-8.
34. Tilg H, Vogel W, Wiedermann CJ et al. Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease. Hepatol 1993; 18:1132-8.
35. Mc Cormick SE, Goodman ZD, Maydonovitch CL, Sjogren MH. Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C. Am J Gastroenterol 1996; 91:1516-22.
36. Morales TG, Samplier RE, Bhattacharya A. Liver histology in individuals with positive markers for HCV and normal or minimally elevated aminotransferases. Am J Gastroenterol 1994; 89:1674-9.
37. Haber MM, West AB, Haber AD. Relationship of aminotransferases to liver histology status in chronic hepatitis C. Am J Gastroenterol 1995; 90:1250-7.
38. Volpes R, van den Oord JJ, De Vos R, Desmet VJ. Hepatic expression of type A and type B receptors for tumor necrosis factor. J Hepatol 1992; 14:361-9.